Navigation Links
Emory Healthcare Uses SciHealth to Improve Patient Satisfaction
Date:1/25/2008

Data transparency improves patient satisfaction scores

ATLANTA, Jan. 25 /PRNewswire/ -- In an effort to more effectively measure individual performance and improve patient satisfaction scores, Emory Healthcare implemented SciHealth INSIGHT. By incorporating patient satisfaction benchmarks established through Press Ganey with INSIGHT, Emory Healthcare increased their overall Press Ganey score by 2 points within 24 months. In addition, individual measures of patient satisfaction also increased significantly.

"With INSIGHT, we are able to provide better transparency into the data that supports our organizational benchmarks," says Redge Hanna, Emory Healthcare's Director of Service Performance. "Having a wide range of clinical, financial and operational performance indicators in one place helps drive the vital results with real-time facts behind them."

Various aspects of patient satisfaction helped to drive the overall increase. One example, food services, yielded a 4 point increase in the score. Patient wait times at Emory Clinics also dropped -- also increasing the score by nearly 4 points. During the same period, Emory experienced another one point increase in their score for Patients Likelihood To Recommend Services To Others.

"We are committed to bringing greater transparency to leading healthcare organizations like Emory," says Bill Leander, SciHealth CEO. "By providing a single source of truth when executing an initiative, organizations like Emory are better equipped to quickly target resources appropriately for improvement."

In 2007, Emory Healthcare was ranked by US News & World Report as one of America's Best Hospitals -- with seven specialty areas ranking in the top 50 nationwide. Emory Healthcare has 1,184 licensed patient beds across 3 hospitals, 9,000 employees and more than 20 health centers located throughout Metro Atlanta.

About SciHealth, Inc.

SciHealth, Inc. is a leading healthcare perform
'/>"/>

SOURCE SciHealth, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. Brain Circuits That Suppress Memory Found
2. Lack of imagination in older adults linked to declining memory
3. Memory Pharmaceuticals Receives Nasdaq Notification Related to Minimum Bid Price
4. Drug Found to Create New Connections in Brain, Restoring and Improving Memory
5. Understand How Sleep Impacts Learning and Memory
6. People with rare type of memory loss still sensitive to others, study shows
7. First Cognitive Training to Demonstrate Immediate Generalizability Through Standardized Assessments of Memory
8. Brain Exercises Sharpen Memory in Older Adults
9. The hormone of darkness: melatonin could hurt memory formation at night
10. Memory Pharmaceuticals Appoints Paul Blake to Board of Directors
11. Memory Pharmaceuticals Announces Positive Phase 2a Results for MEM 3454 in Alzheimers Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... 16 Smart Balance, Inc. (Nasdaq: SMBL ... authorized a two-year stock repurchase program of up to ... program demonstrates the confidence we have in the prospects ... long-term value for all of our shareholders, while at ... Stephen Hughes, Smart Balance, Inc. Chairman and Chief Executive ...
(Date:12/16/2009)... Immucor, Inc. (Nasdaq: BLUD ), a global leader ... industry, today announced that Paul D. Mintz, M.D. has ... director, effective January 1, 2010. ,, Dr. Mintz ... for more than 30 years. He is a tenured ... Virginia School of Medicine. He also serves as director ...
(Date:12/16/2009)... 16 As a result of C3: Colorectal ... peer reviewed cancer research program is included in the ... This new cancer research program will research cancers, like ... prostate, lung and ovarian cancer research programs run by ... ,, The $15 million in funding for this ...
(Date:12/16/2009)... teams led by the Wellcome Trust Sanger Institute announce ... All cancers are caused by mutations in the DNA ... lifetime. The studies, of a malignant melanoma and a ... the mutations in the genomes of two cancers. , ... year: almost all are associated with smoking. The number ...
(Date:12/16/2009)... Access to Quality, Cost-Effective Care , ... Washington, D.C. ... debated the best ways to rein in runaway costs while providing ... important part of the ongoing discussion includes how to ensure patients ... doctors of medicine (MDs) or osteopathy (DOs). In both the ...
Breaking Medicine News(10 mins):Health News:Smart Balance Authorizes Stock Repurchase Program 2Health News:Immucor Appoints New Board Director 2Health News:House Creates New Cancer Research Program 2Health News:House Creates New Cancer Research Program 3Health News:Lung cancer and melanoma laid bare 2Health News:Lung cancer and melanoma laid bare 3Health News:Lung cancer and melanoma laid bare 4Health News:Lung cancer and melanoma laid bare 5Health News:Lung cancer and melanoma laid bare 6Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 2Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 3Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 4Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 5
... reason why smoking is bad for health. ,It seems that ... that protects against heart disease in their blood. The discovery ... risk of heart attacks than non-smokers. ,Paraoxonase is ... and blocking the blood vessels. A team of Swiss researchers ...
... old age appears to be linked to intellectual impairment over ... the Institute of Psychiatry in London carried out a community ... than 630 people aged 65 and over. Smoking and drinking ... volunteers' intellectual powers were also assessed. After excluding those who ...
... analysis, it is better to give radiation therapy before surgery ... as surgery can reduce the risk of recurrence. Generally the ... Scandinavia and the Netherlands, the therapy is given before surgery ... afterwards.// ,An analysis of 8000 patients, led by ...
... The fear of biological weapons such as anthrax may be ... experts. Long-term social or psychological damage could be the result ... letter to the British Medical Journal from researchers in the ... not kill many people, for many more, their prospect is ...
... five times more likely to die at birth than those ... carried out by doctors in the north-west of England also ... more likely to have babies with birth defects. ,The ... that babies born to women with diabetes in Swden were ...
... who are most at risk from high blood pressure have ... being neglected. Doctors are often reluctant to treat people with ... high cholesterol or diabetes. Maybe they believe little can be ... or they may worry about lowering blood pressure in a ...
Other Medicine News:Health News:All the more bad, 2
(Date:12/16/2009)... Dec. 16 HealthWarehouse.com, Inc. (OTC Bulletin Board: ... had secured $1 million in 12% per annum short ... facility is an initial drawdown of $500,000, with accrued ... drawdown of $500,000 with accrued interest and principal repayable ... the Company becoming cashflow positive for any calendar month ...
(Date:12/16/2009)... Technologies, Inc. (Pink Sheets: AVXT) ("AVAX" or the ... bridge loan financing (the "2009 Financing") pursuant to ... "Agreement") with Firebird Global Master Fund, Ltd., ("Firebird"). ... convertible promissory note, due June 30, 2010, in ... a warrant to purchase an aggregate of 93,333,333 ...
(Date:12/16/2009)... Dec. 16 Cohera Medical Inc. today ... a study of its lead surgical adhesive product, ... milestone in the company,s progression of the lead ... investigation is a prospective, open-label, randomized study to ... on wound drainage and associated complications in abdominoplasty, ...
Breaking Medicine Technology:HealthWarehouse.com, Inc. Secures $1 Million in Debt Financing 2AVAX Technologies, Inc. Closes Bridge Financing 2AVAX Technologies, Inc. Closes Bridge Financing 3AVAX Technologies, Inc. Closes Bridge Financing 4First Patient Treated in Clinical Study of Cohera Medical's TissuGlu(R) Surgical Adhesive 2First Patient Treated in Clinical Study of Cohera Medical's TissuGlu(R) Surgical Adhesive 312 Local Athletes and Coaches Chosen for U S Wheelchair Basketball Team 58158 112 Local Athletes and Coaches Chosen for U S Wheelchair Basketball Team 58158 2Drenchers 28TM 29 Increases Distribution in Texas 58153 1Drenchers 28TM 29 Increases Distribution in Texas 58153 2InspireMD Announces the Enrollment of the 1st Patient in the MGuard 28TM 29 Israeli Registry InspireMD Will Also Sponsor a Satellite Program Breakfas 14237 1InspireMD Announces the Enrollment of the 1st Patient in the MGuard 28TM 29 Israeli Registry InspireMD Will Also Sponsor a Satellite Program Breakfas 14237 2InspireMD Announces the Enrollment of the 1st Patient in the MGuard 28TM 29 Israeli Registry InspireMD Will Also Sponsor a Satellite Program Breakfas 14237 3
... with Dual Mechanism May Offer Novel Approach to Blood ... ... 16 Pharmacopeia (Nasdaq:,PCOP), an innovator in the discovery and ... first-in-class,Dual Acting Receptor Antagonist (DARA), showed statistically significant,blood pressure reductions ...
... Trial Results Confirm Efficacy for Population Most ... and EMERYVILLE, Calif., May 16 ,Bayer HealthCare ... ONXX ) today announced that Nexavar(R) (sorafenib) ... (HR=0.68;,p-value=0.014) in patients in the Asia-Pacific region ...
Other Medicine Technology:Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 2Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 3Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 4Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 5Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 6Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 7Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 8Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 2Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 3Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 4Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 5Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 6
... use of guaiac as a test for the ... of phenolic compounds present in guaiac to quinones, ... If blood is present, the heme portion of ... manner, catalyzing the release of oxygen from hydrogen ...
... SENSA elitewas designed to improve patient compliance. ... and sample collection options make this fecal ... understand and complete. Diet guidelines are explained ... determine which foods and drugs are okay ...
... The Original MaybeMom™ Mini ... medical diagnostic instument which uses ... her personal menstrual/fertility cycle, including ... ovulation and menstruation to increase ...
... supporting the effectiveness and accuracy of the ... clinical studies. As a woman nears ovulation ... increases, thereby, elevating the salt in her ... is allowed to dry, crystalization occurs. The ...
Medicine Products: